Literature DB >> 683353

A compartmental model for hepatic transport of taurocholic acid in isolated perfused rat liver.

R Kroker, M S Anwer, D Hegner.   

Abstract

In order to characterize the transport of bile acids through the liver and to study the influence of drugs on these processes, a kinetic model for hepatobiliary transport of taurocholic acid (TC) using the isolated perfused liver was developed. After the system was brought to a steady state by infusing TC at a constant rate, a tracer dose of 14C-TC was injected into the medium. The medium disappearance of 14C-TC followed a first-order kinetic with a single rate constant. The plot of the biliary secretion rate of radioactivity versus time revealed a curve composed of at least three exponential components. From the described results and the present knowledge of hepatobiliary transport of bile acids we proposed a three compartment model, composed of a perfusion medium compartment and two liver compartments. Parameters calculated from the model constants agreed well with model-independent estimations. The influence of bromosulfophthalein (BSP) on the kinetic parameters was studied to compare the result with the known effect of BSP on hepatic transport of taurocholic acid. BSP decreased the constant describing the fractional transfer of taurocholic acid from medium into the liver, which is in agreement with the inhibition of hepatic uptake of taurocholic acid by BSP. Thus a three compartment model may adequately define the hepatobiliary transport of taurocholic acid in the isolated perfused rat liver.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 683353     DOI: 10.1007/BF00498056

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

Review 1.  Intrahepatic cholestasis induced by drugs and chemicals.

Authors:  G L Plaa; B G Priestly
Journal:  Pharmacol Rev       Date:  1976-09       Impact factor: 25.468

2.  Effects of concanavalin A on the isolated perfused rat liver.

Authors:  R Kroker; D Hegner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Liver disease-morphologic considerations.

Authors:  H POPPER
Journal:  Am J Med       Date:  1954-01       Impact factor: 4.965

4.  Uptake of taurocholic acid into isolated rat-liver cells.

Authors:  L R Schwarz; R Burr; M Schwenk; E Pfaff; H Greim
Journal:  Eur J Biochem       Date:  1975-07-15

5.  The age dependence of bile acid metabolism in rats.

Authors:  R Kroker; M S Anwer; D Hegner
Journal:  Aktuelle Gerontol       Date:  1977-10

6.  A simple and sensitive assay of total serum bile acids.

Authors:  F Mashige; K Imai; T Osuga
Journal:  Clin Chim Acta       Date:  1976-07-01       Impact factor: 3.786

Review 7.  Mechanisms and control of secretion of bile water and electrolytes.

Authors:  S Erlinger; D Dhumeaux
Journal:  Gastroenterology       Date:  1974-02       Impact factor: 22.682

8.  Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat.

Authors:  J J Gumucio; V D Valdivieso
Journal:  Gastroenterology       Date:  1971-09       Impact factor: 22.682

9.  Cholic acid uptake and isolated rat hepatocytes.

Authors:  M S Anwer; R Kroker; D Hegner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-11

10.  Uptake of bile acids by perfused rat liver.

Authors:  J Reichen; G Paumgartner
Journal:  Am J Physiol       Date:  1976-09
View more
  2 in total

1.  Membrane transport in hepatic clearance of drugs. I: Extended hepatic clearance models incorporating concentration-dependent transport and elimination processes.

Authors:  Y Kwon; M E Morris
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

2.  Pharmacokinetic modeling of the sinusoidal efflux of anionic ligands from the isolated perfused rat liver: the influence of albumin.

Authors:  J H Proost; H M Nijssen; C B Strating; D K Meijer; G M Groothuis
Journal:  J Pharmacokinet Biopharm       Date:  1993-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.